Profil
David Feltquate currently works at iTeos Therapeutics, Inc., as Chief Medical Officer from 2024.
Dr. Feltquate also formerly worked at Novartis, Inc., as Chairman-Precision Medicine Leadership Team from 2020 to 2021, Bristol Myers Squibb Co., as Head-Early Clinical Development from 2016 to 2019, and Palleon Pharmaceuticals, Inc., as Chief Medical Officer from 2021 to 2024.
Dr. Feltquate received his undergraduate degree from Massachusetts Institute of Technology and doctorate degree from UMass Chan Medical School.
Aktive Positionen von David Feltquate
| Unternehmen | Position | Beginn |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 05.08.2024 |
Ehemalige bekannte Positionen von David Feltquate
| Unternehmen | Position | Ende |
|---|---|---|
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2024 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Corporate Officer/Principal | 01.06.2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.10.2019 |
Ausbildung von David Feltquate
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Palleon Pharmaceuticals, Inc.
Palleon Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops glyco-immunology-based therapies to treat cancer and inflammatory diseases | Health Technology |
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
















